Group
Genomics
5 themes63 tickers
10D rank#3of 142 groups
Dive into Genomics, where we explore who's at the cutting edge of gene editing, sequencing hardware, and who interprets all that genetic data. These companies are all about unlocking life's code for biotech and creating healthcare breakthroughs.
Genomics '25: Gene Editing & Genetic Meds+38.03%20.0%
Genomics '25: Genomics Tools & Automation+75.54%20.0%
Genomics '25: Molecular Diagnostics & Clinical Genomics+76.60%20.0%
Genomics '25: Sequencing Hardware+31.94%20.0%
Genomics '25: Synthentic Biology & Biofoundries+50.29%20.0%
As of Aug 24, 2026, 4:48 AM ET
Themes in this group
Build 20260824T084825
| Genomics '25: Sequencing Hardware | 7 | $84.44B | $591.05B | +3.73% | +9.65% | +17.26% | +13.16% | +20.66% | +31.94% | +64.75% | -43.45% | +26.05% | +32.82% | +17.90% | +64.76% | +5.20% | -2.40% |
| Genomics '25: Molecular Diagnostics & Clinical Genomics | 18 | $6.38B | $114.90B | +4.10% | +9.42% | +23.35% | +29.64% | +32.84% | +76.60% | +155.61% | +113.43% | +42.54% | +61.99% | +51.64% | +127.47% | +12.04% | +14.35% |
| Genomics '25: Synthentic Biology & Biofoundries | 12 | $2.67B | $32.10B | +3.02% | +7.92% | +17.41% | +21.40% | +61.73% | +50.29% | +48.14% | -48.16% | +17.78% | +24.88% | +75.78% | +81.52% | +3.95% | +23.58% |
| Genomics '25: Gene Editing & Genetic Meds | 15 | $1.51B | $22.69B | +2.00% | +5.93% | +11.16% | +16.78% | +23.65% | +38.03% | +8.99% | -56.70% | +2.56% | +4.78% | +9.72% | +99.67% | +6.83% | +10.55% |
| Genomics '25: Genomics Tools & Automation | 14 | $36.27B | $507.83B | +0.69% | +5.86% | +14.40% | +12.68% | +55.20% | +75.54% | +33.65% | -15.03% | +32.68% | +58.41% | +41.96% | +85.94% | +1.84% | +14.82% |
Default: 10D ↓ · Click headers to sort · Shift+click secondary